Last reviewed · How we verify
AbobotulinumtoxinA 300 UNT — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
AbobotulinumtoxinA 300 UNT (AbobotulinumtoxinA 300 UNT) — University Foot and Ankle Foundation.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| AbobotulinumtoxinA 300 UNT TARGET | AbobotulinumtoxinA 300 UNT | University Foot and Ankle Foundation | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- AbobotulinumtoxinA 300 UNT CI watch — RSS
- AbobotulinumtoxinA 300 UNT CI watch — Atom
- AbobotulinumtoxinA 300 UNT CI watch — JSON
- AbobotulinumtoxinA 300 UNT alone — RSS
Cite this brief
Drug Landscape (2026). AbobotulinumtoxinA 300 UNT — Competitive Intelligence Brief. https://druglandscape.com/ci/abobotulinumtoxina-300-unt. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab